Keytruda and Fatigue: What Users Say (Page 2)
Reviews for Keytruda
- Kik...
- Taken for 6 months to 1 year
- February 22, 2025
For Breast Cancer "Not really happy about the many side effects I am experiencing! Daily headaches, extreme fatigue, mild shortness of breath, rapid heartbeat, sweating, feeling cold, nerve pain, bone, muscle, and joint pain, decreased appetite, abdominal pain that is always present and gets worse every time I eat, mucus in stools, nausea unrelated to eating, tingling and random stabbing nerve pain. I have 3 more treatments, and I’m finished unless the TNBC comes back. My oncologist has given me the choice to stop the Keytruda infusions if I can’t tolerate the side effects, but I’m afraid that the cancer will come back! The pathology report from my mastectomy showed a complete response to the chemotherapy and no positive sentinel or other lymph nodes, so at present, I am cancer-free. I want to stay that way, so I’ll keep doing the infusions unless my oncologist says they have to be stopped. I can’t describe if it worked or if it was the other chemotherapy drugs that worked. Despite side effects, I’ll continue."
- Agg...
- November 11, 2024
"I’ve now had 4 infusion treatments with Keytruda. The last CT showed that the bone lesions were stable. I’m hoping that the next bone scan will show that there has been healing in the impacted areas. I’m not having any unexpected adverse reactions to the drug. My CMP results are all within normal range, and my CBC continues to improve. One of my lesions was on the top of my skull (I was headed to a bit of a point), but now I can barely feel any difference in that area. While I did have several rounds of radiation therapy to all of the other lesions, I had no treatments in that area. My team chose Keytruda because genetic testing showed that I have a very high MSI, and other mutations, as does my HR+ cancer. My level of pain is tolerable, my appetite has somewhat decreased, and for a few days after infusion I do feel a bit more fatigued."
Frequently asked questions
- What is the success rate of Keytruda?
- How long does it take for Keytruda to work?
- What are monoclonal antibodies?
- How is Keytruda used for lung cancer?
- Sta...
- August 22, 2024
For Breast Cancer "It is working... in combination with chemo. My tumors are shrinking. Lots of side effects. Colitis, nausea, blurred vision, muscle pain, headache, back pain, loss of energy... could be the chemo."
- Joh...
- Taken for 6 months to 1 year
- August 25, 2024
For Non Small Cell Lung Cancer "Very good so far. Almost a year, and only now a loose stool. Not had too bad a time, some sleepiness, dizziness, fatigue."
Are you taking this medicine?
Your review helps others make informed decisions.- DJD...
- Taken for 1 to 6 months
- May 14, 2024
For Melanoma, Metastatic "I have had 5 treatments so far. Side effects are minimal, mostly fatigue some days. I don't know how it is working yet to reduce the cancer but will be having a scan in a few weeks to determine that."
- Doc...
- Taken for 6 months to 1 year
- July 23, 2024
For Bladder Cancer "Weakness, colitis, neuropathy, dizziness, lack of energy. Cancer seems to be going away."
See also:
Trodelvy
Trodelvy (sacituzumab govitecan) is a targeted therapy used to treat breast cancer (triple-negative ...
Enhertu
Enhertu is a treatment for breast cancer, stomach cancer, and non-small cell lung cancer with HER2 ...
Verzenio
Verzenio is used to treat early and advanced-stage hormone receptor-positive, HER2-negative breast ...
Opdivo Qvantig
Opdivo Qvantig is used to treat adults with melanoma, non-small cell lung cancer, renal cell ...
Rybrevant
Rybrevant is used to treat advanced non-small cell lung cancer (NSCLC) in adults that has certain ...
Kisqali
Kisqali (ribociclib) is used to treat a certain type of advanced metastatic breast cancer. Includes ...
Opdivo
Opdivo is used to treat many cancers, such as melanoma, non-small cell lung cancer, malignant ...
Adriamycin
Adriamycin is used for acute lymphoblastic leukemia, acute myeloblastic leukemia, bladder cancer ...
Imfinzi
Imfinzi (durvalumab) is an immunotherapy used to treat types of lung cancer (NSCLC, SCLC), bile ...
Are you taking this medicine?
Your review helps others make informed decisions.More about Keytruda (pembrolizumab)
- Keytruda consumer information
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (257)
- Drug images
- Side effects
- Dosage information
- Patient tips
- During pregnancy
- Support group
- FDA approval history
- Drug class: anti-PD-1 and PD-L1 monoclonal antibodies (immune checkpoint inhibitors)
- Breastfeeding
- En español
For Breast Cancer "I have received 15 infused doses of Keytruda every 21 days as well as chemotherapy since March 2024. My last dose was April 2025. I’ve had fatigue, a rash on my abdomen and back, and a numb tongue and lips for the last 2 months or so. My skin is scaly. I’m cancer-free now."